Peptide mass: 10mg Bacteriostatic water: 2mL Concentration: 10mg 2mL = 5 mg/mL = 5,000 mcg/mL Peptide per unit (100-unit syringe): 5 mg 100 = 0.05 mg/unit = 50 mcg/unit If research protocol calls for 250 mcg per research unit: 250 mcg 50 mcg/unit = 5 units on the syringe Total doses per vial at 250 mcg each: 10,000 mcg 250 mcg = 40 research doses That single 10mg vial, reconstituted with 2mL of bacteriostatic water, provides 40 research doses of 250 mcg each, drawn to the 5-unit mark on a standard insulin syringe
Combined with TB-500 (wound healing) and KPV (skin anti-inflammation), the blend could support skin repair processes
Dosing, duration, monitoring, and adjustment guidelines
This innovative synthetic peptide represents the next generation of metabolic therapeutics, demonstrating unprecedented efficacy in clinical trials for obesity and type 2 diabetes management
The process is quick, and pressure may be applied afterward to reduce any minor bleeding or discomfort